GlassScriptPhysician profile
Jose Nieves
NPI 1548599269
$12,889.11
in general payments reported to CMS, 2019-2025
35 companies · $2,883 in 2025
The $2,883 reported for 2025 was more than what 82% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $263 · 2021: $20.00 · 2022: $595 · 2023: $4,227 · 2024: $4,902 · 2025: $2,883.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Education: $185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,825.37 |
| Education | $185.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,877.92 | 2019-2025 | Fasenra, Airsupra, Breztri |
| Glaxosmithkline, LLC. | $1,727.61 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| United Therapeutics Corporation | $1,478.88 | 2023-2025 | Tyvaso, Tyvaso, Remodulin |
| Actelion Pharmaceuticals US, INC. | $1,313.33 | 2019-2025 | Uptravi, Opsumit, Opsynvi |
| Regeneron Healthcare Solutions, INC. | $952.88 | 2022-2025 | Dupixent |
| Mallinckrodt Hospital Products INC. | $866.33 | 2022-2025 | Acthar |
| Boehringer Ingelheim Pharmaceuticals, INC. | $610.20 | 2019-2025 | Ofev, Spiriva, Stiolto Respimat |
| Mylan Specialty L.P. | $570.25 | 2022-2024 | Yupelri |
| Genzyme Corporation | $554.98 | 2022-2025 | |
| Baxter Healthcare | $281.27 | 2022-2024 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Ani Pharmaceuticals, INC. | $280.62 | 2023-2025 | Purified Cortrophin Gel |
| Takeda Pharmaceuticals U.S.A., INC. | $259.56 | 2022-2025 | Glassia, Cuvitru |
| Verona Pharma, INC. | $242.68 | 2025 | Ohtuvayre |
| Merck Sharp & Dohme LLC | $220.32 | 2023-2025 | Winrevair, Capvaxive |
| Jazz Pharmaceuticals INC. | $194.77 | 2024-2025 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insmed, INC. | $178.12 | 2024-2025 | Arikayce |
| Inogen, INC. | $177.23 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Grifols USA, LLC | $158.36 | 2019-2025 | Prolastin-C Liquid |
| Viatris Specialty LLC | $130.02 | 2025 | Yupelri |
| Novartis Pharmaceuticals Corporation | $124.52 | 2023-2025 | |
| Amgen INC. | $111.28 | 2023-2025 | Tezspire |
| Bayer Healthcare Pharmaceuticals INC. | $93.12 | 2019-2023 | |
| Becton, Dickinson and Company | $91.86 | 2024 | Fluency Endovascular Stent Graft |
| Genentech USA, INC. | $83.77 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $78.99 | 2025 | |
| Fisher & Paykel Healthcare INC | $33.05 | 2024 | Fisher & Paykel Healthcare |
| Csl Behring | $30.03 | 2024 | Hizentra |
| Janssen Pharmaceuticals, INC | $26.83 | 2022 | |
| Pulmonx Corporation | $24.75 | 2023 | Chartis Catheter, Zephyr Endobronchial Valve, Zephyr Delivery Catheter |
| Electromed, INC. | $22.83 | 2024 | Smartvest |
| Pbg Puerto Rico LLC | $20.00 | 2021 | |
| Philips North America LLC | $19.80 | 2025 | Vest Therapy Und |
| Pfizer INC. | $18.35 | 2019 | |
| Pfizer Pharmaceuticals LLC | $18.00 | 2019 | |
| Phadia US INC. | $16.60 | 2023 | Immunocap |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Nieves listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.